INFEX Therapeutics
Dawn Watson is currently the Director at FinStra Ltd, where Dawn provides financial and strategic business advice to small and medium-sized businesses and start-ups. Dawn is also serving as the CFO at INFEX Therapeutics, a key part of the UK's response to the global threat from Antimicrobial Resistance. In addition, Dawn previously held roles such as WCA Curling Development Officer at the Welsh Curling Association, Business Mentor at Business Wales, and Director of Finance at Aquila BioMedical, Microvisk, and Solus Scientific. Dawn holds a BAcc in Accountancy from the University of Glasgow.
This person is not in any teams
INFEX Therapeutics
We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.